Stem cells and bioactive scaffolds as a treatment for traumatic brain injury

Current Stem Cell Research and Therapy

Volumn 6, Issue 3, 2011, Pages 208-220

  Stabenfeldt, Sarah E ^a   Irons, Hillary R ^a   Laplaca, Michelle C ^a  

^a Emory University   (United States)

Author keywords

Cell transplantation; Stem cell; Stroke; Tissue engineering; Traumatic brain injury

Indexed keywords

TISSUE SCAFFOLD;

ADULT STEM CELL; ARTICLE; EMBRYONIC STEM CELL; FETAL TISSUE TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; NEURAL STEM CELL; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE REGENERATION; TRAUMATIC BRAIN INJURY;

ANIMALS; BIOMIMETIC MATERIALS; BRAIN INJURIES; CELL SURVIVAL; CLINICAL TRIALS AS TOPIC; HUMANS; NERVE REGENERATION; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 80051725785     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488811796575396     Document Type: Article

References (207)

1. Faul M, Xu L, Wald MM, Coronado VG. Traumatic brain injury in the United States: emergency department visits, hospitalizations, and deaths. N.C.f.I.a.P.a.C. Centers for the Disease Control and Prevention, Editor. 2010.
2. Thurman DJ, Alverson C, Dunn KA, Guerrero J, Sniezek JE. Traumatic brain injury in the United States: A public health perspective. J Head Trauma Rehabil 1999; 14(6): 602-15.
3. Warden D. Military TBI during the Iraq and Afghanistan wars. J Head Trauma Rehabil 2006; 21(5): 398-402.
4. Healthy People 2010 report, U.S.D.o.H.a.H. Services, Editor. 2010, Government Printing Office: Washington, D.C.
5. Bramlett, HM, WD Dietrich. Quantitative structural changes in white and gray matter 1 year following traumatic brain injury in rats. Acta Neuropathol (Berl) 2002; 103(6): 607-14.
6. Conti AC, Raghupathi R, Trojanowski JQ, McIntosh TK. Experimental brain injury induces regionally distinct apoptosis during the acute and delayed post-traumatic period. J Neurosci 1998; 18(15): 5663-72.
7. Chen S, Pickard JD, Harris NG. Time course of cellular pathology after controlled cortical impact injury. Experimental Neurology 2003; 182(1): 87-102.
8. Pierce JE, Smith DH, Trojanowski JQ, McIntosh TK. Enduring cognitive, neurobehavioral and histopathological changes persist for up to one year following severe experimental brain injury in rats. Neuroscience 1998; 87(2): 359-69.
9. McIntosh TK, Saatman KE, Raghupathi R, et al. The molecular and cellular sequelae of experimental traumatic brain injury: pathogenetic mechanisms. Neuropathol Appl Neurobiol 1998; 24(4): 251-67.
10. Raghupathi R. Cell death mechanisms following traumatic brain injury. Brain Pathol 2004; 14(2): 215-22.
11. Huang RQ, Cheng HL, Zhao XD, et al. Preliminary study on the effect of trauma-induced secondary cellular hypoxia in brain injury. Neurosci Lett 2010; 473(1): 22-7.
12. Fawcett JW, Asher RA. The glial scar and central nervous system repair. Brain Research Bulletin 1999; 49(6): 377-391.
13. Busch SA, Silver J. The role of extracellular matrix in CNS regeneration. Curr Opin Neurobiol 2007; 17(1): 120-7.
14. Guidelines for the management of severe traumatic brain injury. J Neurotrauma 2007; 24 Suppl 1: S1-106.
15. Narayan RK, Michel ME, Ansell B, et al. Clinical trials in head injury. J Neurotrauma 2002; 19(5): 503-57.
16. Marklund N, Bakshi A, Castelbuono DJ, Conte V, McIntosh TK. Evaluation of pharmacological treatment strategies in traumatic brain injury. Curr Pharm Des 2006; 12(13): 1645-80.
17. Xiong Y, Mahmood A, Chopp M. Emerging treatments for traumatic brain injury. Expert Opin Emerg Drugs 2009; 14(1): 67- 84.
18. Veenith T, Goon SSh, Burnstein RM. Molecular mechanisms of traumatic brain injury: the missing link in management. World J Emerg Surg 2009; 4: 7.
19. Wong J, Hoe NW, Zhiwei F, Ng I. Apoptosis and traumatic brain injury. Neurocrit Care 2005; 3(2): 177-82.
20. Zhang X, Chen Y, Jenkins LW, Kochanek PM, Clark RS. Benchto- bedside review: Apoptosis/programmed cell death triggered by traumatic brain injury. Crit Care 2005; 9(1): 66-75.
21. Byrnes KR, Faden AI. Role of cell cycle proteins in CNS injury. Neurochem Res 2007; 32(10): 1799-807.
22. Faden AI. Pharmacological treatment of central nervous system trauma. Pharmacol Toxicol 1996; 78(1): 12-7.
23. Clausen T, Bullock R. Medical treatment and neuroprotection in traumatic brain injury. Curr Pharm Des 2001; 7(15): 1517-32.
24. Royo NC, Shimizu S, Schouten JW, Stover JF, McIntosh TK. Pharmacology of traumatic brain injury. Curr Opin Pharmacol 2003; 3(1): 27-32.
25. Maas AI, Marmarou A, Murray GD, Steyerberg EW. Clinical trials in traumatic brain injury: current problems and future solutions. Acta Neurochir Suppl 2004; 89: 113-8.
26. Saltzman WM, Mak MW, Mahoney MJ, Duenas ET, Cleland JL. Intracranial delivery of recombinant nerve growth factor: release kinetics and protein distribution for three delivery systems. Pharm Res 1999; 16(2): 232-40.
27. Tabata Y, Gutta S, Langer R. Controlled delivery systems for proteins using polyanhydride microspheres. Pharm Res 1993; 10(4): 487-96.
28. Aebischer P, Winn SR, Tresco PA, Jaeger CB, Greene LA. Transplantation of polymer encapsulated neurotransmitter secretingcells: effect of the encapsulation technique. J Biomech Eng 1991; 113(2): 178-83.
29. During MJ, Freese A, Deutch AY, et al. Biochemical and behavioral recovery in a rodent model of Parkinson's disease following stereotactic implantation of dopamine-containing liposomes. Exp Neurol 1992; 115(2): 193-9.
30. Lu D, Sanberg PR, Mahmood A, et al. Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury. Cell Transplant 2002; 11(3): 275-81.
31. Riess P, Zhang C, Saatman KE, et al. Transplanted neural stem cells survive, differentiate, and improve neurological motor function after experimental traumatic brain injury. Neurosurgery 2002; 51(4): 1043-52; discussion 1052-4.
32. Shear DA, Tate MC, Archer DR, et al. Neural progenitor cell transplants promote long-term functional recovery after traumatic brain injury. Brain Res 2004; 1026(1): 11-22.
33. Mahmood A, Lu D, Qu C, Goussev A, Chopp M. Long-term recovery after bone marrow stromal cell treatment of traumatic brain injury in rats. J Neurosurg 2006; 104(2): 272-7.
34. Riess P, Molcanyi M, Bentz K, et al. Embryonic stem cell transplantation after experimental traumatic brain injury dramatically improves neurological outcome, but may cause tumors. J Neurotrauma 2007; 24(1): 216-25.
35. Dihné M, Bernreuther C, Hagel C, Wesche KO, Schachner M. Embryonic stem cell-derived neuronally committed precursor cells with reduced teratoma formation after transplantation into the lesioned adult mouse brain. Stem Cells 2006; 24(6): 1458-66.
36. Mahmood A, Lu D, Chopp M. Marrow stromal cell transplantation after traumatic brain injury promotes cellular proliferation within the brain. Neurosurgery 2004; 55(5): 1185-93.
37. Mahmood A, Lu D, Yi L, Chen JL, Chopp M. Intracranial bone marrow transplantation after traumatic brain injury improving functional outcome in adult rats. J Neurosurg 2001; 94(4): 589-95.
38. Hagan M, Wennersten A, Meijer X, Holmin S, Wahlberg L, Mathiesen T. Neuroprotection by human neural progenitor cells after experimental contusion in rats. Neurosci Lett 2003; 351(3): 149-52.
39. Gao J, Prough DS, McAdoo DJ, et al. Transplantation of primed human fetal neural stem cells improves cognitive function in rats after traumatic brain injury. Exp Neurol 2006; 201(2): 281-92.
40. Yan J, Welsh AM, Bora SH, Snyder EY, Koliatsos VE. Differentiation and tropic/trophic effects of exogenous neural precursors in the adult spinal cord. J Comp Neurol 2004; 480(1): 101-14.
41. Lu P, Jones LL, Snyder EY, Tuszynski MH. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol 2003; 181(2): 115-29.
42. Ourednik J, Ourednik V, Lynch WP, Schachner M, Snyder EY. Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat Biotechnol 2002; 20(11): 1103-10.
43. Lladó J, Haenggeli C, Maragakis NJ, Snyder EY, Rothstein JD. Neural stem cells protect against glutamate-induced excitotoxicity and promote survival of injured motor neurons through the secretion of neurotrophic factors. Mol Cell Neurosci 2004; 27(3): 322-31.
44. Rafuse VF, Soundararajan P, Leopold C, Robertson HA. Neuroprotective properties of cultured neural progenitor cells are associated with the production of sonic hedgehog. Neuroscience 2005; 131(4): 899-916.
45. Wong AM, Hodges H, Horsburgh K. Neural stem cell grafts reduce the extent of neuronal damage in a mouse model of global ischaemia. Brain Res 2005; 1063(2): 140-50.
46. Chopp M, Li Y. Treatment of neural injury with marrow stromal cells. Lancet Neurol 2002; 1(2): 92-100.
47. Pluchino S, Zanotti L, Rossi B, et al. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 2005; 436(7048): 266-71.
48. Liu S, Qu Y, Stewart TJ, et al. Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc Natl Acad Sci USA 2000; 97(11): 6126-31.
49. Kondziolka D, Wechsler L, Achim C. Neural transplantation for stroke. J Clin Neurosci 2002; 9(3): 225-30.
50. Sladek JR Jr, Redmond DE Jr, Collier TJ, et al. Fetal dopamine neural grafts: extended reversal of methylphenyltetrahydropyridine-induced parkinsonism in monkeys. Prog Brain Res 1988; 78: 497-506.
51. Shindo T, Matsumoto Y, Wang Q, Kawai N, Tamiya T, Nagao S. Differences in the neuronal stem cells survival, neuronal differentiation and neurological improvement after transplantation of neural stem cells between mild and severe experimental traumatic brain injury. J Med Invest 2006; 53(1-2): 42-51.
52. Longhi L, Zanier ER, Royo N, Stocchetti N, McIntosh TK. Stem cell transplantation as a therapeutic strategy for traumatic brain injury. Transpl Immunol 2005; 15(2): 143-8.
53. Seledtsov VI, Rabinovich SS, Parlyuk OV, et al. Cell transplantation therapy in re-animating severely head-injured patients. Biomed Pharmacother 2005; 59(7): 415-20.
54. Walker PA, Shah SK, Harting MT, Cox CS Jr. Progenitor cell therapies for traumatic brain injury: barriers and opportunities in translation. Dis Model Mech 2009; 2(1-2): 23-38.
55. Watts C, Dunnett SB. Towards a protocol for the preparation and delivery of striatal tissue for clinical trials of transplantation in Huntington's disease. Cell Transplant 2000; 9(2): 223-34.
56. Lindvall O, Björklund A. Cell replacement therapy: helping the brain to repair itself. NeuroRx 2004; 1(4): 379-81.
57. Koutouszis TK, Emerich DF, Borlongan CV, Freeman TB, Cahill DW, Sanberg PR. Cell transplantation for central nervous system disorders. Crit Rev Neurobiol 1994; 8(3): 125-62.
58. Subramanian T. Cell transplantation for the treatment of Parkinson's disease. Semin Neurol 2001; 21(1): 103-115.
59. Labbe R, Firl A Jr, Mufson EJ, Stein DG. Fetal brain transplant: reduction of cognitive deficits in rats with frontal cortex lesions. Science 1983; 221(4609): 470-2.
60. Sinson G, Voddi M, McIntosh TK. Combined fetal neural transplantation and nerve growth factor infusion: effects on neurological outcome following fluid-percussion brain injury in the rat. J Neurosurg 1996; 84: 655-62.
61. Stein DG. Fetal brain tissue grafting as therapy for brain dysfunctions: Unanswered questions, unknown factors, and practical concerns. J Neurosurg Anesthesiol 1991; 3(3): 170-89.
62. Stein, DG, Glasier MM. An overview of developments in research on recovery from brain injury. Adv Exp Med Biol 1992; 325: 1-22.
63. Guan K, Chang H, Rolletschek A, Wobus AM. Embryonic stem cell-derived neurogenesis. Retinoic acid induction and lineage selection of neuronal cells. Cell Tissue Res 2001; 305(2): 171-6.
64. Kim DS, Kim JY, Kang M, Cho MS, Kim DW. Derivation of functional dopamine neurons from embryonic stem cells. Cell Transplant 2007; 16(2): 117-23.
65. Dhara SK, Stice SL. Neural differentiation of human embryonic stem cells. J Cell Biochem 2008; 105(3): 633-40.
66. Bjorklund A. Cell therapy for Parkinson's disease: problems and prospects. Novartis Found Symp 2005; 265: 174-86; discussion 187, 204-211.
67. Winkler C, Kirik D, Bjorklund A. Cell transplantation in Parkinson's disease: how can we make it work? Trends Neurosci 2005; 28(2): 86-92.
68. Kallos MS, Sen A, Behie LA. Large-scale expansion of mammalian neural stem cells: a review. Med Biol Eng Comput 2003; 41(3): 271-82.
69. Lim DA, Huang YC, Alvarez-Buylla A. The adult neural stem cell niche: lessons for future neural cell replacement strategies. Neurosurg Clin N Am 2007; 18(1): 81-92, ix.
70. Kornblum, HI. Introduction to neural stem cells. Stroke 2007; 38(2 Suppl): 810-6.
71. Taupin P. Autologous transplantation in the central nervous system. Indian J Med Res 2006; 124(6): 613-8.
72. Rao MS. Multipotent and restricted precursors in the central nervous system. Anat Rec 1999; 257(4): 137-48.
73. Whittemore SR, Morassutti DJ, Walters WM, Liu RH, Magnuson DS. Mitogen and substrate differentially affect the lineage restriction of adult rat subventricular zone neural precursor cell populations. Exp Cell Res 1999; 252(1): 75-95.
74. Gage FH. Mammalian neural stem cells. Science 2000; 287(5457): 1433-8.
75. Kukekov VG, Laywell ED, Suslov O, et al. Multipotent stem/progenitor cells with similar properties arise from two neurogenic regions of adult human brain. Exp Neurol 1999; 156(2): 333-44.
76. Gates MA, Thomas LB, Howard EM, et al. Cell and molecular analysis of the developing and adult mouse subventricular zone of the cerebral hemispheres. J Comp Neurol 1995; 361(2): 249-66.
77. McKay R. Stem cells in the central nervous system. Science 1997; 276(5309): 66-71.
78. Philips MF, Mattiasson G, Wieloch T, et al. Neuroprotective and behavioral efficacy of nerve growth factor-transfected hippocampal progenitor cell transplants after experimental traumatic brain injury. J Neurosurg 2001; 94(5): 765-74.
79. Schouten JW, Fulp CT, Royo NC, et al. A review and rationale for the use of cellular transplantation as a therapeutic strategy for traumatic brain injury. J Neurotrauma 2004; 21(11): 1501-38.
80. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126(4): 663-76.
81. Zhou H, Wu S, Joo JY, et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009; 4(5): 381-4.
82. Woltjen K, Michael IP, Mohseni P, et al. Piggybac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009; 458(7239): 766-70.
83. Wernig M, Zhao JP, Pruszak J, et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci USA 2008; 105(15): 5856-61.
84. Karumbayaram S, Novitch BG, Patterson M, et al. Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells 2009; 27(4): 806-11.
85. Dimos JT, Rodolfa KT, Niakan KK, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008; 321(5893): 1218-21.
86. Soldner F, Hockemeyer D, Beard C, et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009; 136(5): 964-77.
87. Hu BY, Weick JP, Yu J, et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci USA 2010; 107(9): 4335-40.
88. Salewski RP, Eftekharpour E, Fehlings MG. Are induced pluripotent stem cells the future of cell-based regenerative therapies for spinal cord injury? J Cell Physiol 2010; 222(3): 515-21.
89. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276(5309): 71-4.
90. Mezey E, Chandross KJ. Bone marrow: a possible alternative source of cells in the adult nervous system. Eur J Pharmacol 2000; 405(1-3): 297-302.
91. Herzog EL, Chai L, Krause DS. Plasticity of marrow-derived stem cells. Blood 2003; 102(10): 3483-93.
92. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8(4): 315-7.
93. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418(6893): 41-9.
94. Verfaillie CM. Adult stem cells: assessing the case for pluripotency. Trends Cell Biol 2002; 12(11): 502-8.
95. Fried A, Shamay A, Wientroub S, Benayahu D. Phenotypic expression of marrow cells when grown on various substrata. J Cell Biochem 1996; 61(2): 246-254.
96. Gronthos S, Simmons PJ, Graves SE, Robey PG. Integrin-mediated interactions between human bone marrow stromal precursor cells and the extracellular matrix. Bone 2001; 28(2): 174-81.
97. Corti S, Locatelli F, Strazzer S, Guglieri M, Comi GP. Neuronal generation from somatic stem cells: current knowledge and perspectives on the treatment of acquired and degenerative central nervous system disorders. Curr Gene Ther 2003; 3(3): 247-72.
98. Mezey E, Key S, Vogelsang G, Szalayova I, Lange GD, Crain B. Transplanted bone marrow generates new neurons in human brains. Proc Natl Acad Sci USA 2003; 100(3): 1364-9.
99. Cogle CR, Yachnis AT, Laywell ED, et al. Bone marrow transdifferentiation in brain after transplantation: a retrospective study. Lancet 2004; 363(9419): 1432-7.
100. Sostak P, Theil D, Stepp H, Roeber S, Kretzschmar HA, Straube A. Detection of bone marrow-derived cells expressing a neural phenotype in the human brain. J Neuropathol Exp Neurol 2007; 66(2): 110-6.
101. Brazelton TR, Rossi FM, Keshet GI, Blau HM. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 2000; 290(5497): 1775-9.
102. Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 30(1): 42-8.
103. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringdén O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003; 31(10): 890-6.
104. Liu CT, Yang YJ, Yin F, et al. The immunobiological development of human bone marrow mesenchymal stem cells in the course of neuronal differentiation. Cell Immunol 2006; 244(1): 19-32.
105. Glennie S, Soeiro I, Dyson PJ, Lam EW, Dazzi F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005; 105(7): 2821-7.
106. Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363(9419): 1439-41.
107. Dezawa M. Insights into autotransplantation: the unexpected discovery of specific induction systems in bone marrow stromal cells. Cell Mol Life Sci 2006; 63(23): 2764-72.
108. Tang Y, Yasuhara T, Hara K, et al. Transplantation of bone marrow-derived stem cells: a promising therapy for stroke. Cell Transplant 2007; 16(2): 159-69.
109. Shi M, Li J, Liao L, et al. Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice. Haematologica 2007; 92(7): 897-904.
110. Cui X, Chen J, Zacharek A, et al. Nitric oxide donor upregulation of stromal cell-derived factor-1/chemokine (CXC motif) receptor 4 enhances bone marrow stromal cell migration into ischemic brain after stroke. Stem Cells 2007; 25(11): 2777-85.
111. Potapova IA, Brink PR, Cohen IS, Doronin SV. Culturing of human mesenchymal stem cells as three-dimensional aggregates induces functional expression of CXCR4 that regulates adhesion to endothelial cells. J Biol Chem 2008; 283(19): 13100-7.
112. Marchionini DM, Collier TJ, Pitzer MR, Sortwell CE. Reassessment of caspase inhibition to augment grafted dopamine neuron survival. Cell Transplant 2004; 13(3): 273-82.
113. Boockvar JA, Schouten J, Royo N, et al. Experimental traumatic brain injury modulates the survival, migration, and terminal phenotype of transplanted epidermal growth factor receptoractivated neural stem cells. Neurosurgery 2005; 56(1): 163-71.
114. Kim DE, Tsuji K, Kim YR, et al. Neural stem cell transplant survival in brains of mice: assessing the effect of immunity and ischemia by using real-time bioluminescent imaging. Radiology 2006; 241(3): 822-30.
115. Kanelos SK, McDeavitt JT. Neural transplantation: potential role in traumatic brain injury. J Head Trauma Rehabil 1998; 13(6): 1-9.
116. Picard-Riera N, Nait-Oumesmar B, Baron-Van Evercooren A. Endogenous adult neural stem cells: limits and potential to repair the injured central nervous system. J Neurosci Res 2004; 76(2): 223-31.
117. Bakshi A, Keck CA, Koshkin VS, et al. Caspase-mediated cell death predominates following engraftment of neural progenitor cells into traumatically injured rat brain. Brain Research 2005; 1065: 8-19.
118. Tate MC, Shear DA, Hoffman SW, Stein DG, Archer DR, LaPlaca MC. Fibronectin promotes survival and migration of primary neural stem cells transplanted into the traumatically injured mouse brain. Cell Transplantation 2002; 11(3): 283-295.
119. Chen J, Li Y, Wang L, Lu M, Chopp M. Caspase inhibition by ZVAD increases the survival of grafted bone marrow cells and improves functional outcome after MCAo in rats. J Neurol Sci 2002; 199(1-2): 17-24.
120. Emgard M, Hallin U, Karlsson J, Bahr BA, Brundin P, Blomgren K. Both apoptosis and necrosis occur early after intracerebral grafting of ventral mesencephalic tissue: a role for protease activation. J Neurochem 2003; 86(5): 1223-32.
121. Duan WM, Zhao LR, Westerman M, et al. Enhancement of nigral graft survival in rat brain with the systemic administration of synthetic fibronectin peptide V. Neuroscience 2000; 100(3): 521- 530.
122. Marchionini DM, Collier TJ, Camargo M, McGuire S, Pitzer M, Sortwell CE. Interference with anoikis-induced cell death of dopamine neurons: implications for augmenting embryonic graft survival in a rat model of Parkinson's disease. J Comp Neurol 2003; 464(2): 172-179.
123. Bakshi A, Shimizu S, Keck CA, et al. Neural progenitor cells engineered to secrete GDNF show enhanced survival, neuronal differentiation and improve cognitive function following traumatic brain injury. Eur J Neurosci 2006; 23(8): 2119-34.
124. Borlongan CV, Saporta S, Poulos SG, Othberg A, Sanberg PR. Viability and survival of hNT neurons determine degree of functional recovery in grafted ischemic rats. Neuroreport 1998; 9(12): 2837-42.
125. Hattiangady B, Rao MS, Zaman V, Shetty AK. Incorporation of embryonic CA3 cell grafts into the adult hippocampus at 4-months after injury: effects of combined neurotrophic supplementation and caspase inhibition. Neuroscience 2006; 139(4): 1369-83.
126. Rao MS, Hattiangady B, Shetty AK. Fetal hippocampal CA3 cell grafts enriched with FGF-2 and BDNF exhibit robust long-term survival and integration and suppress aberrant mossy fiber sprouting in the injured middle-aged hippocampus. Neurobiol Dis 2006; 21(2): 276-90.
127. Shamekh R, Newcomb J, Mallery J, et al. Survival of rat or mouse ventral mesencephalon neurons after cotransplantation with rat sertoli cells in the mouse striatum. Cell Transplant 2005; 14(8): 551-64.
128. Schumm MA, Castellanos DA, Frydel V, Sagen J. Improved neural progenitor cell survival when cografted with chromaffin cells in the rat striatum. Exp Neurol 2004; 185(1): 133-42.
129. Sortwell, CE, TJ Collier, JR Sladek, Jr. Co-grafted embryonic striatum increases the survival of grafted embryonic dopamine neurons. J Comp Neurol 1998; 399(4): 530-40.
130. Micci MA, Pattillo MT, Kahrig KM, Pasricha PJ. Caspase inhibition increases survival of neural stem cells in the gastrointestinal tract. Neurogastroenterol Motil 2005; 17(4): 557- 64.
131. Bregman BS, Reier PJ. Neural tissue transplants rescue axotomized rubrospinal cells from retrograde death. J Comp Neurol 1986; 244(1): 86-95.
132. Lescaudron L, Stein DG. Functional recovery following transplants of embryonic brain tissue in rats with lesions of visual, frontal and motor cortex: problems and prospects for future research. Neuropsychologia 1990; 28(6): 585-99.
133. Soares HD, Sinson GP, McIntosh TK. Fetal hippocampal transplants attenuate CA3 pyramidal cell death resulting from fluid percussion brain injury in the rat. J Neurotrauma 1995; 12(6): 1059-67.
134. Valouskova V, Galik J. Unilateral grafting of fetal neocortex into a cortical cavity improves healing of a symmetric lesion in the contralateral cortex of adult rats. Neurosci Lett 1995; 186(2-3): 103-6.
135. Vanderwolf CH, Fine A, Cooley RK. Intracortical grafts of embryonic basal forebrain tissue restore low voltage fast activity in rats with basal forebrain lesions. Exp Brain Res 1990; 81(2): 426- 32.
136. Stokes BT, Reier PJ. Oxygen transport in intraspinal fetal grafts: graft-host relations. Exp Neurol 1991; 111(3): 312-23.
137. Redmond DE, Sladek JR Jr, Roth RH, et al. Fetal neuronal grafts in monkeys given methylphenyltetrahydropyridine. Lancet 1986; 1(8490): 1125-7.
138. Dunnett SB, Bjorklund A, Lindvall O. Cell therapy in Parkinson's disease-stop or go? Nat Rev Neurosci 2001; 2(5): 365-9.
139. Lesný P, De Croos J, Prádný M, et al. Polymer hydrogels usable for nervous tissue repair. J Chem Neuroanat 2002; 23(4): 243-7.
140. Schmidt C, Leach J. Neural tissue engineering: Strategies for repair and regeneration. Ann Rev Biomed Engin 2003; 5: 293-347.
141. Willerth SM, Sakiyama-Elbert SE. Approaches to neural tissue engineering using scaffolds for drug delivery. Adv Drug Deliv Rev 2007; 59(4-5): 325-38.
142. Garcia AJ, Vega MD, Boettiger D. Modulation of cell proliferation and differentiation through substrate-dependent changes in fibronectin conformation. Mol Biol Cell 1999; 10(3): 785-98.
143. Keselowsky BG, Collard DM, Garcia AJ. Surface chemistry modulates fibronectin conformation and directs integrin binding and specificity to control cell adhesion. J Biomed Mater Res A 2003; 66A(2): 247-59.
144. Stabenfeldt SE, García AJ, LaPlaca MC. Thermoreversible laminin-functionalized hydrogel for neural tissue engineering. J Biomed Mater Res A 2006; 77A(4): 718-25.
145. Dai WG, Belt J, Saltzman WM. Cell-Binding Peptides Conjugated to Poly(Ethylene Glycol) Promote Neural Cell-Aggregation. Bio-Technology 1994; 12(8): 797-801.
146. Lutolf MP, Lauer-Fields JL, Schmoekel HG, et al. Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics. Proc Natl Acad Sci USA 2003; 100(9): 5413-8.
147. Kim J, Park Y, Tae G, et al. Synthesis and characterization of matrix metalloprotease sensitive-low molecular weight hyaluronic acid based hydrogels. J Mater Sci Mater Med 2008; 19(11): 3311-8.
148. Coats B, Margulies SS. Material properties of porcine parietal cortex. J Biomech 2006; 39(13): 2521-5.
149. Gefen A, Margulies SS. Are in vivo and in situ brain tissues mechanically similar? J Biomech 2004; 37(9): 1339-52.
150. Prange MT, Margulies SS. Regional, directional, and agedependent properties of the brain undergoing large deformation. J Biomech Eng 2002; 124(2): 244-52.
151. Thibault KL, Margulies SS. Age-dependent material properties of the porcine cerebrum: effect on pediatric inertial head injury criteria. J Biomech 1998; 31(12): 1119-26.
152. Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell 2006; 126(4): 677-89.
153. Leipzig ND, Xu C, Zahir T, Shoichet MS. Functional immobilization of interferon-gamma induces neuronal differentiation of neural stem cells. J Biomed Mater Res A 2010; 93(2): 625-33.
154. Seidlits SK, Khaing ZZ, Petersen RR, et al. The effects of hyaluronic acid hydrogels with tunable mechanical properties on neural progenitor cell differentiation. Biomaterials 2010; 31(14): 3930-40.
155. Saha K, Keung AJ, Irwin EF, et al. Substrate modulus directs neural stem cell behavior. Biophys J 2008; 95(9): 4426-38.
156. Stile RA, Chung E, Burghardt WR, Healy KE. Poly(Nisopropylacrylamide)-based semi-interpenetrating polymer networks for tissue engineering applications. Effects of linear poly(acrylic acid) chains on rheology. J Biomater Sci Polym Ed 2004; 15(7): 865-78.
157. Yu X, Bellamkonda RV. Tissue-engineered scaffolds are effective alternatives to autografts for bridging peripheral nerve gaps. Tissue Eng 2003; 9(3): 421-30.
158. Tate MC, Shear DA, Hoffman SW, Stein DG, LaPlaca MC. Biocompatibility of methylcellulose-based constructs designed for intracerebral gelation following experimental traumatic brain injury. Biomaterials 2001; 22(10): 1113-23.
159. Jeong B, Kim SW, Bae YH. Thermosensitive sol-gel reversible hydrogels. Adv Drug Deliv Rev 2002; 54(1): 37-51.
160. Cullen, DK, Stabenfeldt SE, Simon CM, Tate CC, Laplaca MC. In vitro neural injury model for optimization of tissue-engineered constructs. J Neurosci Res 2007; 85(16): 3642-51.
161. Clausen T, Khaldi A, Zauner A, et al. Cerebral acid-base homeostasis after severe traumatic brain injury. J Neurosurg 2005; 103(4): 597-607.
162. Park, TG, Hoffman AS. Synthesis and Characterization of pHand/ or Temperature-sensitive Hydrogels. J Appl Polym Sci 1992; 46: 659-71.
163. Kim HK, Shim WS, Kim SE, et al. Injectable in situ-forming pH/thermo-sensitive hydrogel for bone tissue engineering. Tissue Eng Part A 2009; 15(4): 923-33.
164. Hubbell JA. Bioactive biomaterials. Curr Opin in Biotechnol 1999; 10(2): 123-29.
165. Lutolf MP, Hubbell JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 2005; 23(1): 47-55.
166. Boontheekul T, Mooney DJ. Protein-based signaling systems in tissue engineering. Curr Opin Biotechnol 2003; 14(5): 559-65.
167. Patterson J, Martino MM, Hubbell JA. Biomimetic materials in tissue engineering. Materials Today 2010; 13(1-2): 14-22.
168. Saporta S, Borlongan C, Moore J, et al. Microcarrier enhanced survival of human and rat fetal ventral mesencephalon cells implanted in the rat striatum. Cell Transplant 1997; 6(6): 579-84.
169. Tate CC, Shear DA, Tate MC, Archer DR, Stein DG, LaPlaca MC. Laminin and fibronectin scaffolds enhance neural stem cell transplantation into the injured brain. J Tissue Eng Regen Med 2009; 3(3): 208-17.
170. Lu D, Mahmood A, Qu C, Hong X, Kaplan D, Chopp M. Collagen scaffolds populated with human marrow stromal cells reduce lesion volume and improve functional outcome after traumatic brain injury. Neurosurgery 2007; 61(3): 596-602; discussion 602-3.
171. Qu C, Xiong Y, Mahmood A, et al. Treatment of traumatic brain injury in mice with bone marrow stromal cell-impregnated collagen scaffolds. J Neurosurg 2009; 111(4): 658-65.
172. Hern DL, Hubbell JA. Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing. Journal of Biomedical Materials Research 1998; 39(2): 266-76.
173. King WJ, Jongpaiboonkit L, Murphy WL. Influence of FGF2 and PEG hydrogel matrix properties on hMSC viability and spreading. J Biomed Mater Res A 2010; 93(3): 1110-23.
174. Carson AE, Barker TH. Emerging concepts in engineering extracellular matrix variants for directing cell phenotype. Regen Med 2009; 4(4): 593-600.
175. Bowditch RD, Hariharan M, Tominna EF, et al. Identification of a novel integrin binding site in fibronectin. Differential utilization by beta 3 integrins. J Biol Chem 1994; 269(14): 10856-63.
176. Aota S, Nomizu M, Yamada KM. The short amino acid sequence Pro-His-Ser-Arg-Asn in human fibronectin enhances cell-adhesive function. J Biol Chem 1994; 269(40): 24756-61.
177. Webb K, Budko E, Neuberger TJ, Chen SZ, Schachner M, Tresco PA. Substrate-bound human recombinant L1 selectively promotes neuronal attachment and outgrowth in the presence of astrocytes and fibroblasts. Biomaterials 2001; 22(10): 1017-28.
178. Powell SK, Kleinman HK. Neuronal laminins and their cellular receptors. Int J Biochem Cell Biol 1997; 29(3): 401-14.
179. Freire E, Gomes FC, Linden R, Neto VM, Coelho-Sampaio T. Structure of laminin substrate modulates cellular signaling for neuritogenesis. J Cell Sci 2002; 115(24): 4867-76.
180. Chothia C, Jones EY. The molecular structure of cell adhesion molecules. Annual Review of Biochemistry 1997; 66: 823-62.
181. Heaton MB, Swanson DJ. The influence of laminin on the initial differentiation of cultured neural tube neurons. J Neurosci Res 1988; 19(2): 212-8.
182. Prestoz L, Relvas JB, Hopkins K, et al. Association between integrin-dependent migration capacity of neural stem cells in vitro and anatomical repair following transplantation. Mol Cell Neurosci 2001; 18(5): 473-84.
183. Tate MC, Garcia AJ, Keselowsky BG, Schumm MA, Archer DR, LaPlaca MC. Specific Beta-1 integrins mediate adhesion, migration, and differentiation of neural progenitors derived from the embryonic striatum. Mol Cell Neurosci 2004; 27(1): 22-31.
184. Leone DP, Relvas JB, Campos LS, et al. Regulation of neural progenitor proliferation and survival by b1 integrins. J Cell Sci 2005; 118(Pt 12): 2589-99.
185. Kearns, SM, Laywell ED, Kukekov VK, Steindler DA. Extracellular matrix effects on neurosphere cell motility. Experimental Neurology 2003; 182(1): 240-4.
186. Jacques TS, Relvas JB, Nishimura S, et al. Neural precursor cell chain migration and division are regulated through different beta 1 integrins. Development 1998; 125(16): 3167-77.
187. Qian, L, Saltzman WM. Improving the expansion and neuronal differentiation of mesenchymal stem cells through culture surface modification. Biomaterials 2004; 25: 1331-7.
188. Nakajima M, Ishimuro T, Kato K, et al. Combinatorial protein display for the cell-based screening of biomaterials that direct neural stem cell differentiation. Biomaterials 2007; 28(6): 1048-60.
189. Flanagan LA, Rebaza LM, Derzic S, Schwartz PH, Monuki ES. Regulation of human neural precursor cells by laminin and integrins. J Neurosci Res 2006; 83(5): 845-56.
190. Campos LS, Leone DP, Relvas JB, et al. Beta1 integrins activate a MAPK signalling pathway in neural stem cells that contributes to their maintenance. Development 2004; 131(14): 3433-44.
191. Gu Z, Cui J, Brown S, et al. A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J Neurosci 2005; 25(27): 6401-8.
192. Gary DS, Milhavet O, Camandola S, Mattson MP. Essential role for integrin linked kinase in Akt-mediated integrin survival signaling in hippocampal neurons. J Neurochem 2003; 84(4): 878-90.
193. Gary, DS, MP Mattson. Integrin signaling via the PI3-kinase-Akt pathway increases neuronal resistance to glutamate-induced apoptosis. J Neurochem 2001; 76(5): 1485-96.
194. Le Bellego F, Pisselet C, Huet C, Monget P, Monniaux D. Laminin-alpha6beta1 integrin interaction enhances survival and proliferation and modulates steroidogenesis of ovine granulose cells. J Endocrinol 2002; 172(1): 45-59.
195. Sonoda Y, Watanabe S, Matsumoto Y, Aizu-Yokota E, Kasahara T. FAK is the upstream signal protein of the phosphatidylinositol 3-kinase-Akt survival pathway in hydrogen peroxide-induced apoptosis of a human glioblastoma cell line. J Biol Chem 1999; 274(15): 10566-70.
196. Bondar VM, Sweeney-Gotsch B, Andreeff M, Mills GB, McConkey DJ. Inhibition of the phosphatidylinositol 3'-kinase- AKT pathway induces apoptosis in pancreatic carcinoma cells in vitro and in vivo. Mol Cancer Ther 2002; 1(12): 989-97.
197. Learish RD, Bruss MD, Haak-Frendscho M. Inhibition of mitogenactivated protein kinase kinase blocks proliferation of neural progenitor cells. Brain Res Dev Brain Res 2000; 122(1): 97-109.
198. Mahoney MJ, Anseth KS. Contrasting effects of collagen and bFGF-2 on neural cell function in degradable synthetic PEG hydrogels. J Biomed Mater Res A 2007; 81(2): 269-78.
199. Aizawa, Y, Leipzig N, Zahir T, Shoichet M. The effect of immobilized platelet derived growth factor AA on neural stem/progenitor cell differentiation on cell-adhesive hydrogels. Biomaterials 2008; 29(35): 4676-83.
200. Johnson PJ, Tatara A, Shiu A, Sakiyama-Elbert SE. Controlled release of neurotrophin-3 and platelet-derived growth factor from fibrin scaffolds containing neural progenitor cells enhances survival and differentiation into neurons in a subacute model of SCI. Cell Transplant 2010; 19(1): 89-101.
201. Li Y, Chen J, Chen XG, et al. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 2002; 59(4): 514-23.
202. Li Y, Chopp M, Chen J, et al. Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice. J Cereb Blood Flow Metab 2000; 20(9): 1311-9.
203. Lu D, Mahmood A, Wang L, Li Y, Lu M, Chopp M. Adult bone marrow stromal cells administered intravenously to rats after traumatic brain injury migrate into brain and improve neurological outcome. Neuroreport 2001; 12(3): 559-63.
204. Qu R, Li Y, Gao Q, Shen L, et al. Neurotrophic and growth factor gene expression profiling of mouse bone marrow stromal cells induced by ischemic brain extracts. Neuropathology 2007; 27(4): 355-63.
205. Crigler L, Robey RC, Asawachaicharn A, Gaupp D, Phinney DG. Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol 2006; 198(1): 54-64.
206. Harms KM, Li L, Cunningham LA. Murine neural stem/progenitor cells protect neurons against ischemia by HIF-1alpha-regulated VEGF signaling. PLoS One 2010; 5(3): e9767.
207. Jin, K, Y Zhu, Y Sun, XO Mao, L Xie, DA Greenberg. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci USA 2002; 99(18): 11946-50.